Synergistic Analgesia of Duloxetine in Phantom Limb Pain: a Randomized Controlled Trial.

Synergistic Analgesia of Duloxetine in Phantom Limb Pain of Amputees From Bone Tumors: a Randomized Controlled Trial.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027038

Enrollment

Unknown

Registered

2019-10-29

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phantom Limb Pain

Interventions

trial group:administration of duloxetine 60mg

control group:administration of placebo

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Bone tumor patients, phantom limb pain after amputation, high school education degree or above, enough understanding and description ability, volunteers signed the informed consent.

Exclusion criteria

Exclusion criteria: Administration history of psychiatric or analgesic drugs 2 weeks previously

Design outcomes

Primary

Measure	Time frame
NRS;	—

Countries

China

Contacts

Public ContactShuang Jiang

Cancer Hospital of China Medical University

jiangshuang@cancerhosp-ln-cmu.com+86 18900917667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026